A pilot study of calcineurin inhibitors (CNIs) and steroid avoidance immunosuppressive protocol among living donor kidney transplant recipients

Yonsei Medical Journal

Volumn 45, Issue 6, 2004, Pages 1143-1148

  Oh, Henry K ^a   Ding, Philip ^a   Satmary, Nancy A ^a  

^a ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Anti proliferative agents; Calcineurin; Immunosuppression; Rejection; Wound dehiscence

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; METHYLPREDNISOLONE SODIUM SUCCINATE; MONOCLONAL ANTIBODY CD3; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; BODY WEIGHT DISORDER; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; MOUTH ULCER; PILOT STUDY; RECIPIENT; RISK ASSESSMENT; SHORT COURSE THERAPY; WOUND DEHISCENCE;

EID: 12344318325     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2004.45.6.1143     Document Type: Article

References (24)

1. Starzl TE, Klintermalm GBG, Weil R, Proter KA, Jwatsuki S, Schroter GPJ, et al. Cyclosporin-A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet 1981;153:486-94.
2. Paul LC. Immunosuppressive drug-induced toxicities compromising the half-life of renal allografts. Transplant Proc 1998;30:7S-13S.
3. Bennett WM, Demattos A, Meyer MM, Andoh T, Barry JM. Chronic cyclosporine nephropathy. Kidney Int 1996;50:1089-100.
4. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of nonrenal organ. N Engl J Med 2003;349: 931-40.
5. Kjellstrand CM. Side effects of steroids and their treatment. Transplant Proc 1975;7:123-9.
6. Popovtzer MM, Pinnggera W, Katz FH, Corman JL, Robinette J, Lanois B, et al. Variations in arterial blood pressure after kidney transplantation; Relation to renal function, plasma renin activity, and the dose of prednisone. Circulation 1973;47:1297-305.
7. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991; 325:544-50.
8. Davis GF. Adverse effects of corticosteroids. Clin Dermatol 1986;4:161-9.
9. Hill MN, Grossman RA, Feldman HI, Hurwitz S, Dafoe DC. Changes in causes of death after renal transplantation 1966-1987. Am J Kidney Dis 1991;17:512-8.
10. Veenstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE. Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 1999;33:829-39.
11. Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients; a Meta-analysis. J Am Soc Nephrol 1993;4:1300-5.
12. Steroid Withdrawal Study Group. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study. Transplantation 1999;68:1865-74.
13. Birkland SA. Steroid-free immunosuppression in renal transplantation. Transplantation 2001;71:1089-90.
14. Ratcliffe PJ, Dudley CR, Higgins RM, Firth JD, Smith B, Morris PJ. Randomized controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996;348:643-8.
15. Hollander AA, Hene RJ, Hermans J, van Es LA, van der Woude FJ. Late prednisone withdrawal in cyclosporin-treated kidney transplant patients: A randomized study. J Am Soc Nephrol 1997;8:294-301.
16. Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000;11:1910-7.
17. Matas AJ, Ramcharan T, Paraskevas S, Gillingham KJ, Dunn DL, Gruessner RW, et al. Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study. Am J Transplant 2001;1:278-83.
18. Kaufman DB, Leventhal JR, Koffron AJ, Gallon LG, Parker MA, Fryer JP, et al. A prospective study of corticosteroid elimination in simultaneous pancreas- kidney transplantation. Comparison of two maintenance immunosuppression protocols: tacrolimus/ mycophenolate mofetil versus tacrolimus/sirolimus. Transplantation 2002;73:169-77.
19. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003;349:2326-33.
20. Tran HT, Acharya MK, McKay DB, Sayegh MH, Carpenter CB, Auchincloss HJR, et al. Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids. J Am Soc Nephrol 2000;11:1903-9.
21. Vincenti F, Ramos E, Brattstrom C, Cho S, Ekberg H, Grinyo J, et al. Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation. Transplantation 2001;71:1282-7.
22. Donati D, Ambrosini A, Marconi A, Mazzola E. Calcineurin-inhibitor-free immunosuppressive regimen for marginal donors/recipients of kidney transplantation. Transplant Proc 2002;34:1678-80.
23. Kreis H, et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 2002;69:1252-60.
24. Flechner SM, Goldfarb DA, Modlin C, et al. Kidney transplantation without calcineurin inhibitor drugs permits maximum recovery of renal function [Abstract #20] second international congress on immunosuppression. San Diego, CA, December 2001.